Drugs / ABACAVIR HYDROXYACETATE
ABACAVIR HYDROXYACETATE
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02949388 Comparator | Nov 2016 → Nov 2017 | psoriasis | Innovation Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02494479 Comparator | Aug 2015 → Apr 2016 | psoriasis | Cellceutix Corporation | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABACAVIR HYDROXYACETATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297418 ↗ |
| Known as | abacavir glycolate | “At a subset of sites, blood samples for determination of plasma concentrations of Prurisol (abacavir glycolate) and abacavir, it's metabolite, will be obtained from subjects...” NCT02949388 ↗ |
| Known as | Prurisol | “At a subset of sites, blood samples for determination of plasma concentrations of Prurisol (abacavir glycolate) and abacavir, it's metabolite, will be obtained from subjects...” NCT02949388 ↗ |
| Modality | Small molecule | — CHEMBL4297418 ↗ |
| Route | Oral | “Prurisol Administered Orally” NCT02494479 ↗ |